Using smart devices to monitor health in eating disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the potential of smart devices to capture digital biomarkers in individuals diagnosed with eating disorders. By utilizing smartphones and smartwatches, the study aims to collect real-time health data such as heart rate, blood pressure, and respiratory rate, which are crucial for effective monitoring and treatment planning. The research addresses the limitations of traditional manual monitoring methods, which can be time-consuming and may not accurately reflect a patient's health status. The goal is to enhance the management of eating disorders through innovative technology, facilitating better care both in clinical settings and at home.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All participants must be aged 10 years or older.
* Diagnosed with an eating disorder by a clinician as per the World Health Organization\'s ICD-10 (F50.0 through F50.9) or ICD-11 (6B80 - 6B85; 6B8Y, 6B8Z) classification
* Must have a minimum once weekly in-person clinic physical assessment as part of their current treatment plan at the start of the study participation
* Fluent in English
* Capable of reading and understanding the information sheets and consent forms to provide written informed consent.
* For participants aged between 10 and 16 years, parental consent is required first before offering the opportunity to the child. A parent or legal guardian must also be able to read and understand the information sheets and consent forms to provide written informed consent on behalf of the child under 16 years of age.

Exclusion Criteria:

* Active substance use such as drug or alcohol misuse

  * For alcohol consumption of more than 21 units of alcohol per week (1 unit is equivalent to half a pint of beer (285ml), 25ml of spirits, or one glass of wine)
  * Diagnostic coding for current mental and behavioural disorders due to substances (ICD10: F10 through F19; ICD11: QE10 through QE1Z and 6C40 through 6C4H)
* A diagnosis of a neurological disorder, including but not limited to cerebrovascular diseases, either currently or in the past or where the eating disorder for which the participant is being treated is considered aetiologically-secondary to a neurological disorder (e.g. pica secondary to a brain injury).
* A diagnosis of schizophrenia or related psychotic disorder.
* Pregnancy.
* A diagnosis of developmental learning disorder (ICD10 F80.0 through F81.9: ICD11: 6A03) or intellectual disorders (ICD10: F70.0 through F79.9; ICD11 6A00).

Where it's running

• University of Liverpool
  Liverpool, United Kingdom Recruiting

Study contacts

• Principal investigator: Daniel Joyce, MRCPsych — University of Liverpool
• Study coordinator: Richard Andrews, BSc
• Email: research@univa.health
• Phone: +441488892853

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• National Highly Specialized Care for Severe Self-Harm and Eating Disorders in Swedish Youth

  This observational study tests how well NHV, a highly specialized care program, works for children and teens with severe self-harm or eating disorders by asking patients and their parents about their experiences and what changes they notice.

  Recruiting at 2 sites Karolinska Institutet · Stockholm and 1 other locations · NCT07898059

• National Highly Specialized Care for adults with treatment-resistant self-harm and eating disorders (Substudy 1)

  This study tests how people with severe, hard-to-turge self-harm or eating disorders in Sweden experience NHV care and whether the treatment helps with symptoms and daily functioning.

  Recruiting at 2 sites Karolinska Institutet · Stockholm and 1 other locations · NCT07878897

• FlexED: A digital program to help young women see thoughts and feelings about their body in a friendlier way

  This trial tests a smartphone-based, gamified ACT-inspired program called FlexED to help young women and girls at risk for eating disorders see how they think and feel about their bodies, and to see if it can be feasibly spread to more people.

  Recruiting Duke University · Durham, North Carolina · NCT07807774

• Impact of GLP-1 Receptor Agonist Therapy vs Structured Lifestyle on Weight and Health

  This study tests whether starting a GLP-1 receptor agonist for weight loss works differently from a structured diet-and-exercise program in improving heart and metabolic health for adults with overweight or obesity.

  Recruiting Texas Tech University · Lubbock, Texas · NCT07740291

• FlexED: Full Threshold Body-Image Intervention for Young Women

  A mobile, gamified ACT-based program is tested to see if it helps young women with eating disorders feel less distressed about their bodies and reduce symptoms.

  Recruiting Duke University · Durham, North Carolina · NCT07732829

• Four CBT-E formats for Binge Eating Disorder in adults

  This trial tests four different psychotherapy formats to see which best reduces binge-eating episodes in adults with Binge Eating Disorder.

  Recruiting Herlev and Gentofte Hospital · Ballerup Municipality, Capital Region · NCT07698132

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.